Advanced search
Publication Cover
Cancer Investigation Volume 19, 2001 - Issue 8
Submit an article Journal homepage
22
Views
15
CrossRef citations to date
0
Altmetric
Original

Palliative Chemotherapy in Pretreated Patients with Advanced Cancer: Oral Trofosfamide Is Effective in Ovarian Carcinoma

Eberhard Gunsilius Division of Hematology & Oncology, University Hospital, Anichstr. 35, Innsbruck, A-6020, Austria; Division of Hematology & Oncology, University Hospital, Anichstr. 35, Innsbruck, A-6020, Austria
, M.D.,
Thomas Gierlich Tumor Biology Center at the University of Freiburg, Freiburg, Germany
, M.D.,
Klaus Mross Tumor Biology Center at the University of Freiburg, Freiburg, Germany
, M.D.,
Günther Gastl Division of Hematology & Oncology, University Hospital, Anichstr. 35, Innsbruck, A-6020, Austria
, M.D. &
Clemens Unger Tumor Biology Center at the University of Freiburg, Freiburg, Germany
, M.D.
Pages 808-811 | Published online: 30 Nov 2001

REFERENCES

  • Brock N. Pharmakologische Untersuchungen mit Trofosfamid (Ixoten), Einem Neuen Oxazaphosphorinoxid. Med. Monatschr. 1973; 27: 300–394
  • Boos J., Kupker F., Blaschke G., Jürgens H. Trofosfamide Metabolism in Different Species—Ifosfamide Is the Predominant Metabolite. Cancer Chemother. Pharmacol. 1993; 33: 71–76
  • Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting Results of Cancer Treatment. Cancer 1981; 47: 204–214
  • Frondoza C. G., Trivedi D. M., Humphrey R. L. Development and Characterisation of a Cyclophosphamide-Resistant Mouse Plasmocytoma Cell Line. Cancer Treat. Rep. 1982; 66: 1535–1544
  • Norum J. Complete Remission After Repeated Trofosfamide Treatment in Relapsing High-Grade Malignant Non-Hodgkin's Lymphoma-A Case Report. Acta Oncol. 1984; 33: 831
  • Wist E., Risberg T. Trofosfamide in Non-Hodgkin's Lymphoma. A Phase II Study. Acta Oncol. 1991; 30: 819–821
  • Pötzi P., Aiginger P., Kühböck J. Ixoten-Therapie bei Malignen Lymhomen. Acta Med. Austriaca 1979; 6: 247–249
  • Salminen E., Nikanen V., Lindholm L. Trofosfamide Is Effective in Refractory Non-Hodgkins Lymphoma. Eur. J. Cancer 1994; 31A: 2419–2420
  • Blomqvist C., Wiklund T., Pajunen M., Virolainen M., Elomaa I. Oral Trofosfamide: An Active Drug in the Treatment of Soft-Tissue Sarcoma. Cancer Chemother. Pharmacol. 1995; 36: 263–265
  • Falkson G., Falkson H. Trofosfamide in the Treatment of Patients with Cancer. S. Afr. Med. J. 1978; 53: 886–888
  • Mross K., Rüther A., Gierlich T., Unger C. Tumor Growth Control by Oral Trofosfamide in Patients with Metastatic Breast Cancer. Onkologie 1998; 21(1)52–56

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.